510(k) Report

510(k) · Cleared

Cleared

NobelZygoma 45°

K152093510(k) TraditionalCleared Mar 16, 2016232-day reviewClass II21 CFR 872.3640

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nobel Biocare AB · DZE Implant, Endosseous, Root-Form

Cleared on Mar 16, 2016 as substantially equivalent to K070182 (Nobel Biocare AB, 2007) after a 232-day review. Its family tree reaches back 3 generations to 1993. 3 later devices descend from it.

Decided
Mar 16, 2016
Review
232 days
Class
Class II
Product code
DZE
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K925771 (1993). 13 ancestors in all. 3 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 2 other ancestors1995: 3 other ancestors1994: 1 other ancestor1993: 4 other ancestors2017: 1 descendant cleared2025: 1 descendant cleared2018: 1 descendant clearedK925771 · Branemark System Titanium Cover Screws · Nobelpharma USA, Inc. · 1993K970499 · Branemark System Zygomaticus Fixture System · Nobel Biocare Uas, Inc. · 1997K070182 · Zygoma Implant (Immediate Function) · Nobel Biocare AB · 20071990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 2 other ancestors3 generations back: 8 other ancestors 1 generation forward: 2 descendants2 generations forward: 1 descendant K070182 · Zygoma Implant (Immediate Function) · Nobel Biocare AB · 2007K970499 · Branemark System Zygomaticus Fixture System · Nobel Biocare Uas, Inc. · 1997K925771 · Branemark System Titanium Cover Screws · Nobelpharma USA, Inc. · 19930
  1. Root · 3 generations backK925771 Branemark System Titanium Cover ScrewsNobelpharma USA, Inc. · 1993
  2. 2 generations backK970499 Branemark System Zygomaticus Fixture SystemNobel Biocare Uas, Inc. · 1997
  3. 1 generation backK070182 Zygoma Implant (Immediate Function)Nobel Biocare AB · 2007
  4. This deviceK152093 NobelZygoma 45°Nobel Biocare AB · 2016
  5. Descendant · cites it directly · 2 of its ownK161598 NobelZygoma 0°Nobel Biocare AB · 2017
  6. Descendant · cites it directly · 0 of its ownK243834 NobelZygoma TiUltra Implant systemNobel Biocare AB · 2025
  7. Descendant · 2 generations on · 0 of its ownK183069 NobelZygoma 0°Nobel Biocare AB · 2018

Most influential descendants

Showing 3 of 3 · See all
  • K161598NobelZygoma 0°Nobel Biocare AB · 2017 · cites it directly2descendants
  • K243834NobelZygoma TiUltra Implant systemNobel Biocare AB · 2025 · cites it directly0descendants
  • K183069NobelZygoma 0°Nobel Biocare AB · 2018 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K925771Branemark System Titanium Cover ScrewsNobelpharma USA, Inc.1993—
−2K970499Branemark System Zygomaticus Fixture SystemNobel Biocare Uas, Inc.1997—
−1K070182Zygoma Implant (Immediate Function)Nobel Biocare AB2007—
0 (this device)K152093NobelZygoma 45°Nobel Biocare AB2016—
+1K161598NobelZygoma 0°Nobel Biocare AB2017—
+1K243834NobelZygoma TiUltra Implant systemNobel Biocare AB2025—
+2K183069NobelZygoma 0°Nobel Biocare AB2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199340
199410
199530
200520

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
201810
202510
FIG. 1 — Lineage of K152093, 1993–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DZE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DZE device

  1. #1 K211090 ZENEX Implant Systemscore 25.4 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070182Zygoma Implant (Immediate Function)
Summary page 4
…lassification Name: Endosseous Dental Implant (21 CFR 872.3640) Regulatory Class: II Product Code: DZE III.PREDICATE DEVICE Nobel Biocare – Zygoma Implant (K070182) IV. DEVICE DESCRIPTION Nobel Biocare’s NobelZygoma 45° implants are threaded, root-form titanium dental implants int…
Nobel Biocare AB2007—

Also cleared against K070182: 2 other devices →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K161598NobelZygoma 0°Nobel Biocare AB20172
K243834NobelZygoma TiUltra Implant systemNobel Biocare AB20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 9.0 years on median.
  • 1 of the 13 ancestors has a recall of any class.
  • Of its descendants, K161598 (Nobel Biocare AB, 2017) has gone furthest, with 2 descendants of its own.
  • 2 other devices also cite its predicate K070182.

How does its category compare?

All DZE devices

DZE Implant, Endosseous, Root-Form: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · DZE

31in 2025

2007: 432008: 612009: 412010: 342011: 262012: 392013: 422014: 362015: 362016: 402017: 482018: 412019: 312020: 412021: 342022: 342023: 352024: 402025: 312026 (partial year): 15
2007high 61 (2008) · low 26 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DZE

184in 2025

2007: 107 days median2008: 118 days median2009: 110 days median2010: 162 days median2011: 194 days median2012: 174 days median2013: 195 days median2014: 265 days median2015: 215 days median2016: 219 days median2017: 223 days median2018: 200 days median2019: 231 days median2020: 230 days median2021: 182 days median2022: 243 days median2023: 248 days median2024: 222 days median2025: 184 days median2026 (partial year): 194 days median
2007high 265 (2014) · low 107 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DZE

1in 2025

2007: 112008: 42009: 32010: 32012: 112013: 12014: 72015: 32016: 152017: 42018: 42019: 82021: 62024: 12025: 12026 (partial year): 2
2007high 15 (2016) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DZE

465,788in 2025

2007: 2252008: 3932009: 1642010: 3602011: 3622012: 3582013: 3912014: 1,1242015: 2,8942016: 1,1162017: 9,7192018: 12,8922019: 167,0162020: 255,5242021: 479,6182022: 483,2242023: 537,5852024: 473,6292025: 465,788
2007high 537,585 (2023) · low 164 (2009)2025

MAUDE reports naming product code DZE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074310711225
2008611184393
2009411103164
2010341623360
2011261940362
20123917411358
2013421951391
20143626571,124
20153621532,894
201640219151,116
20174822349,719
201841200412,892
2019312318167,016
2020412300255,524
2021341826479,618
2022342430483,224
2023352480537,585
2024402221473,629
2025311841465,788
2026151942—

What is it indicated for?

Nobel Biocare's Zygoma implants are endosseous dental implants intended to be surgically placed in the bone of the upper jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore patient esthetics and chewing function. The Zygoma Implants may be put into immediate function provided that stability requirements detailed in the directions for use are satisfied.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K152093: NobelZygoma 45°.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K152093

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026